San Diego, CA 8/21/14; London, England 8/21/14—Illumina has formed collaborative partnerships with AstraZeneca, Janssen Biotech and Sanofi to develop a universal next-generation sequencing (NGS)–based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multigene panel for therapeutic selection. The partnership involves […]
As part of its move into the clinical market, Illumina has formed a collaboration with pharmaceutical companies AstraZeneca, Janssen Biotech and Sanofi to develop a companion-diagnostic test for oncology based on next-generation sequencing (NGS) (see page 2). Intending to extend the partnership to additional companies, Illumina plans to develop the Universal Oncology Test System, to […]
Company Announcements In May, QIAGEN cofounder Dr. Detlev Riesner stepped down from the Supervisory Board. Dr. Elaine Mardis, codirector of the Genome Institute at Washington University and the Robert E. and Louise F. Dunn Distinguished Professor of Medicine, was proposed as a new member. Endress+Hauser revenues rose over 7% in 2013 to €1.8 billion ($2.4 […]
San Diego, CA 7/16/14—Illumina has purchased Myraqa, a regulatory and quality consulting firm that specializes in IVD, particularly companion diagnostics. The purchase price was undisclosed. Illumina stated that the acquisition adds to its in-house capabilities for clinical readiness and prepares it for its next growth phase in regulated markets. “With Myraqa, Illumina will continue to […]
Hercules, CA 4/10/14; Cambridge, MA 4/10/14—Bio-Rad Laboratories, a provider of products for clinical diagnostics and life science research, has acquired Cambridge, Massachusetts–based GnuBIO, for an undisclosed amount. GnuBIO is the developer of a low-cost, droplet-based, integrated sequencing system that delivers results in hours rather than days. The instrument handles target selection, amplification, sequencing and informatics […]
At a time when large exhibitions seem to be declining in attendance and exhibitor participation, Analytica has clearly established itself as a “must-attend event” based on a proven formula for success. The trade fair took place May 10–13 in Munich, Germany. Held at an outstanding modern venue in the heart of Europe, well planned and […]
Paisley, UK 3/17/14—Thermo Fisher Scientific has acquired Prionics, an animal health diagnostics company, for an undisclosed amount. Headquartered in Zurich, Switzerland, Prionics’ product line includes more than 50 diagnostics test kits, accessories and biochemicals. Prionics will be part of Thermo’s Life Technologies brand. “Prionics adds a unique blend of expertise and diagnostic solutions to new […]
Cambridge, UK 3/24/14 Cambridge, UK 3/27/14—Gene editing technology firm Horizon Discovery has raised £68.6 million ($113.1 million = £0.61 = $1) in its IPO, resulting in gross proceeds of £40 million ($66 million), prior to listing its shares on the UK’s AIM stock exchange on March 27 (see IBO 2/28/14). The firm started trading at […]
On February 6, the NIH announced the Accelerating Medicines Partnership (AMP), a collaboration among the agency, 10 pharmaceutical companies, seven nonprofit organizations and one trade group, the Pharmaceutical Research and Manufacturers of America (PhRMA). The program will be funded with more than $230 million over five years and will focus on three main areas: Alzheimer’s […]
Based on preliminary figures, US federal budget authority for R&D fell 7.1% in fiscal year 2013 (FY13) to $133.5 billion due to the sequestration. In FY12, it declined 0.4%. Nondefense R&D budget authority fell 3.6% to $61.5 billion, compared to a 4.4% increase in FY12. By budget function, nondefense budget R&D authority for health, natural […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
